Letter to BS: Exporting hydroxychloroquine does not seem like a good idea

Although India is helping the SAARC nations with supplies, exporting the medicine to 30 other nations does not seem like a good idea

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
This request from the Brazilian President is, however, not unexpected, as it is commensurate with the global role India is playing amid the coronavirus crisis
Business Standard
2 min read Last Updated : Apr 09 2020 | 11:03 PM IST
Brazilian President Jair M Bolsonaro referred to Ramayana on Hanuman Jayanti while asking Prime Minister Narendra Modi for help in battling the shortage of medical supplies in Brazil due to the onslaught of Covid-19. The Brazilian president was quoted as saying, “Like Lord Hanuman brought the holy medicine from the Himalayas to save the life of Lord Ram’s brother Lakshman... India and Brazil will overcome this global crisis by joining forces...”

This request from the Brazilian President is, however, not unexpected, as it is commensurate with the global role India is playing amid the coronavirus crisis. India has emerged like a messiah as the world fights Covid-19, with more than 30 countries requesting PM Modi to export hydroxychloroquine to fight the virus. Although India is helping the SAARC nations with supplies, exporting the medicine touted to be the "game changer" against the coronavirus to 30 other nations does not seem like a good idea, especially with numbers increasing manifold in our own country.

Gaurav Agarwal  Guwahati

Letters can be mailed, faxed or e-mailed to: 
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg 
New Delhi 110 002 
Fax: (011) 23720201  ·  E-mail: letters@bsmail.in
All letters must have a postal address and phone number

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusLockdownHydroxychloroquinePM Narendra ModiJair Bolsonaro

Next Story